Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wessel van de Veerdonk"'
Autor:
Deborah Jael Herrera, Wessel van de Veerdonk, Daiane Maria Seibert, Moges Muluneh Boke, Claudia Gutiérrez-Ortiz, Nigus Bililign Yimer, Karen Feyen, Allegra Ferrari, Guido Van Hal
Publikováno v:
Gastrointestinal Disorders, Vol 5, Iss 4, Pp 549-579 (2023)
Individualized risk prediction models for colorectal cancer (CRC) play a pivotal role in shaping risk-based screening approaches, garnering attention for use in informed decision making by patients and clinicians. While the incorporation of new predi
Externí odkaz:
https://doaj.org/article/88edd11713d641f484f856109d64ce7e
Autor:
Sylvie Bernaerts, Bert Bonroy, Jo Daems, Romy Sels, Dieter Struyf, Inge Gies, Wessel van de Veerdonk
Publikováno v:
Frontiers in Digital Health, Vol 4 (2022)
Accumulating evidence supports the use of virtual reality (VR) as an effective pain and anxiety management tool for pediatric patients during specific medical procedures in dedicated patient groups. However, VR is still not widely adopted in everyday
Externí odkaz:
https://doaj.org/article/714694e9de214fc2aad13624a06f2ce4
Autor:
Sarah Hoeck, Isabel De Brabander, Marc Peeters, Julie Francart, Wessel van de Veerdonk, Guido Van Hal
Publikováno v:
United European gastroenterology journal
Background Colorectal cancer (CRC) and its precursor lesions are detected at an early stage by CRC screening programmes, which reduce CRC-related mortality. An important quality indicator for CRC screening is the occurrence of interval CRC (IC) betwe
Autor:
Marc Peeters, Guido Van Hal, Wessel van de Veerdonk, Geert Silversmit, Isabel De Brabander, Sarah Hoeck
Publikováno v:
Cancer epidemiology
Background The quantitative faecal immunochemical test (FIT) detects pre-cancerous lesions and colorectal cancer (CRC). Current CRC screening programmes are based upon a binary FIT result. This study evaluates the possibility of personalised risk pre
Publikováno v:
Cancer epidemiology
Introduction Colorectal cancer (CRC) screening generally starts screening by the age of 50 based on guidelines. Lately however, a U.S. guideline recommended to start CRC screening from age 45 and, very recently, two studies were published that addres
Publikováno v:
Preventive medicine
With increasing incidence and mortality, colorectal cancer (CRC) is a growing health problem worldwide. An effective way to address CRC is by screening for fecal (occult) blood by the fecal immunochemical test (FIT). However, there is room for improv